Related Experiment Video
Updated: Jun 12, 2026
06:51
A Minimally Invasive Model of Aortic Stenosis in Swine
Published on: October 20, 2023
A new hemostasis valve for neuroendovascular procedures
1Center for Endovascular Surgery, Beth Israel Hyman-Newman Institute for Neurology and Neurosurgery Roosevelt Hospital, New York, NY - aberenstein@bethisraelny.org.
Summary
The new Guardian Haemostasis Valve minimizes blood loss and stagnation during neuroendovascular procedures. This innovative device reduces thromboembolism risk by improving hemostasis valve function.
Area of Science:
- Neurosurgery
- Interventional Radiology
- Medical Devices
Background:
- Hemostasis valves are crucial in neuroendovascular procedures to prevent thromboembolism.
- Conventional valves can lead to significant blood loss and stagnation, increasing emboli risk.
Purpose of the Study:
- To evaluate the initial clinical experience with the new Guardian Haemostasis Valve.
- To assess the device's efficacy in minimizing blood loss and stagnation.
Main Methods:
- Initial clinical use of the Guardian Haemostasis Valve in neuroendovascular procedures.
- Focus on the valve's continuous sealing mechanism during catheter manipulation.
Main Results:
- The Guardian Haemostasis Valve is designed to minimize blood loss.
- Continuous sealing aims to reduce blood stagnation within the guiding catheter.
Conclusions:
- The Guardian Haemostasis Valve represents a novel approach to hemostasis in neuroendovascular interventions.
- Further experience is needed to fully establish its benefits in reducing thromboembolic events.
